$GHDX GENOMIC HEALTH INC Insider Trading Week 11/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENOMIC HEALTH INC in week 11/2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Option Exercise | M | 27.00 | 1,400 | 37,800 | 17,767 | |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Option Exercise | M | 31.98 | 1,500 | 47,970 | 77,167 | |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Option Exercise | M | 27.48 | 1,800 | 49,464 | 43,653 | |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Option Exercise | M | 27.48 | 1,000 | 27,480 | 45,453 | |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Sell | S | 75.00 | 4,700 | 352,500 | 31,575 | 36.3 K to 31.6 K (-12.96 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Buy | M | 31.98 | 1,500 | 47,970 | 36,275 | 34.8 K to 36.3 K (+4.31 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Buy | M | 27.00 | 1,400 | 37,800 | 34,775 | 33.4 K to 34.8 K (+4.19 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Buy | M | 27.48 | 1,800 | 49,464 | 33,375 | 31.6 K to 33.4 K (+5.70 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Sell | S | 75.12 | 1,000 | 75,122 | 31,575 | 32.6 K to 31.6 K (-3.07 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | Pla Frederic | COO | Buy | M | 27.48 | 1,000 | 27,480 | 32,575 | 31.6 K to 32.6 K (+3.17 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 41,281 | 3,068,962 | 8,458,858 | 8.5 M to 8.5 M (-0.49 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 6,338 | 471,187 | 1,340,144 | 1.3 M to 1.3 M (-0.47 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 1,092 | 81,183 | 263,290 | 264.4 K to 263.3 K (-0.41 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 634 | 47,134 | 169,803 | 170.4 K to 169.8 K (-0.37 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 48 | 3,568 | 50,553 | 50.6 K to 50.6 K (-0.09 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 707 | 52,561 | 184,841 | 185.5 K to 184.8 K (-0.38 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 41,281 | 3,068,962 | 8,458,858 | 8.5 M to 8.5 M (-0.49 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 6,338 | 471,187 | 1,340,144 | 1.3 M to 1.3 M (-0.47 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 1,092 | 81,183 | 263,290 | 264.4 K to 263.3 K (-0.41 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 634 | 47,134 | 169,803 | 170.4 K to 169.8 K (-0.37 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 48 | 3,568 | 50,553 | 50.6 K to 50.6 K (-0.09 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.34 | 707 | 52,561 | 184,841 | 185.5 K to 184.8 K (-0.38 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 86,620 | 6,464,529 | 8,500,139 | 8.6 M to 8.5 M (-1.01 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 13,298 | 992,442 | 1,346,482 | 1.4 M to 1.3 M (-0.98 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 2,293 | 171,129 | 264,382 | 266.7 K to 264.4 K (-0.86 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 1,329 | 99,184 | 170,437 | 171.8 K to 170.4 K (-0.77 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 101 | 7,538 | 50,601 | 50.7 K to 50.6 K (-0.20 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.63 | 1,485 | 110,827 | 185,548 | 187 K to 185.5 K (-0.79 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 90,251 | 6,695,487 | 8,586,759 | 8.7 M to 8.6 M (-1.04 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 13,856 | 1,027,941 | 1,359,780 | 1.4 M to 1.4 M (-1.01 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 2,388 | 177,160 | 266,675 | 269.1 K to 266.7 K (-0.89 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 1,385 | 102,750 | 171,766 | 173.2 K to 171.8 K (-0.80 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 106 | 7,864 | 50,702 | 50.8 K to 50.7 K (-0.21 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.19 | 1,547 | 114,768 | 187,033 | 188.6 K to 187 K (-0.82 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.57 | 413 | 30,795 | 8,677,010 | 8.7 M to 8.7 M (0.00 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.57 | 63 | 4,698 | 1,373,636 | 1.4 M to 1.4 M (0.00 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.57 | 11 | 820 | 269,063 | 269.1 K to 269.1 K (0.00 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.57 | 6 | 447 | 173,151 | 173.2 K to 173.2 K (0.00 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.57 | 7 | 522 | 188,580 | 188.6 K to 188.6 K (0.00 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 42,124 | 3,138,238 | 8,677,423 | 8.7 M to 8.7 M (-0.48 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 6,467 | 481,792 | 1,373,699 | 1.4 M to 1.4 M (-0.47 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 1,115 | 83,068 | 269,074 | 270.2 K to 269.1 K (-0.41 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 647 | 48,202 | 173,157 | 173.8 K to 173.2 K (-0.37 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 49 | 3,651 | 50,808 | 50.9 K to 50.8 K (-0.10 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.50 | 722 | 53,789 | 188,587 | 189.3 K to 188.6 K (-0.38 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 3,068 | 234,915 | 8,719,547 | 8.7 M to 8.7 M (-0.04 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 471 | 36,064 | 1,380,166 | 1.4 M to 1.4 M (-0.03 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 81 | 6,202 | 270,189 | 270.3 K to 270.2 K (-0.03 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 47 | 3,599 | 173,804 | 173.9 K to 173.8 K (-0.03 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 4 | 306 | 50,857 | 50.9 K to 50.9 K (-0.01 %) |
Mar 19 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.57 | 52 | 3,982 | 189,309 | 189.4 K to 189.3 K (-0.03 %) |